PRECISION BIOSCIENCES INC

DTIL NASDAQ
9.61
-0.26
-2.63%
Opening 14:38 08/21 EDT
Open
9.96
Prev Close
9.87
High
9.96
Low
9.61
Volume
28.50K
Avg Vol (3M)
177.95K
52 Week High
19.00
52 Week Low
8.59
% Turnover
0.06%
Market Cap
471.18M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers PRECISION BIOSCIENCES INC DTIL stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Precision BioSciences, Inc. is a genome editing company. The Company is engaged in providing genome engineering technology. The Company’s ARCUS genome editing technology enables the production of specific nucleases that can insert, remove and modify deoxyribonucleic acid (DNA) at any location in a genome. The Company is also engaged in developing genome editing-based product leads for human therapeutic, agricultural and biologics manufacturing applications. The Company’s four product candidates in its CAR T cell development pipeline are PBCAR0191, PBCAR20A, PBCAR269A and PBCAR371A. The Company’s ARCUS platform designed to treat human diseases and create healthy and sustainable food and agricultural solutions. It also developing product candidates in three areas to overcome the limitations of other genome editing technologies: allogeneic CAR T immunotherapy, in vivo gene correction, and food.
MORE >

Recently

Name
Price
%Change